 |
Arachidonic Acid Panel - 1
Mono-oxygenated metabolites of arachidonic acid make up
this panel. These metabolites are formed via the cytochrome P450 and lipoxygenase pathways
and have been implicated in various inflammatory and cardiovascular diseases |
-Details
|
 |
|
|
 |
Arachidonic Acid Panel - 2
Several prostaglandins make up this panel. These metabolites
are formed via the cyclooxygenase pathway and have been implicated in various inflammatory and cardiovascular diseases |
-Details
|
|
|
|
| |
Nicotine/Cotinine
The highly sensitive technique employed allows for the
detection of residues of second-hand smoke in blood and tissue samples. |
-Details
|
|
|
|
| |
Vitamin D Metabolite Panel
The Vitamin D2 and D3 families affect calcium
homeostasis and are implicated in many chronic diseases such as cancer,
hypertension and cardiac disease. Analysis of the 25-hydroxy-D2 and D3
metabolites is the first step in assessing patient Vitamin D status.
Planned future additions to the panel include D2 and D3 residues upstream
and downstream from the 25-hydroxy compounds. |
-Details
|
|
|
|
| |
ADMA Analysis
Asymmetric dimethylarginine (ADMA) is a naturally occurring component of human plasma.
It inhibits the synthesis of nitric oxide and many researchers today agree that ADMA
may play a role in the progression of cardiovascular disease. An assay has been
validated to detect ADMA in human cerebrospinal fluid (CSF).
|
-Details
|
|
|
|
| |
Drug Analysis
Most drugs on this list are either substrates for cytochrome P450 isoforms or various transport proteins.
As such, they serve as biomarkers for enzyme activity and pharmacokinetic processes
|
-Details
|
|
|
|
